https://www.selleckchem.com/products/VX-770.html
Purpose Hearing loss is a significant late effect among childhood cancer survivors. Recent guidelines note insufficient evidence to quantify its natural history or risk associated with specific exposures. We examined the long-term incidence and predictors of hearing loss requiring hearing amplification devices (HADs) using population-based health care data. Methods In Ontario, Canada, HAD costs are subsidized by the Assistive Devices Program (ADP). Ontario children 32.00 Gy. Carboplatin exposure was not associated with HAD. Conclusion Ch
إعجاب
علق
شارك
